AzTrials
AzTrials

NightmaresBERRTNCT02242110

Brief Treatment for Trauma Nightmares in Trauma-exposed Adults With Bipolar Disorder

A study testing ERRT-Bipolar Disorder in people with Nightmares and Post-traumatic Stress Disorder, run by University of Tulsa at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. Though further evidence is needed, ERRT has shown strong support in reducing the number and intensity of nightmares, as well as improving overall sleep… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Nightmares, Post-traumatic Stress Disorder
What is being tested?
ERRT-Bipolar Disorder
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
Jun 2014to 15 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Nightmares at least once per week for the past month
  • Formal diagnosis of Bipolar disorder (I or II)
  • Exposure to traumatic event (1+ months ago)
  • Stable on bipolar medication for at least 2 months

Who cannot join

  • A traumatic event within the last month
  • Intellectual disability
  • Current or recent mania/hypomania within the last 3 months
  • Suicide attempt or hospitalization within the last 3 months
  • Current or untreated substance use disorder within the past 6 months

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Tulsa

    Tulsa, Oklahoma, 74104

Other trials in United States

About this study

Official title: Efficacy of a Brief Treatment for Chronic Nightmares Among Trauma-Exposed Persons With Bipolar Disorder

Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. Though further evidence is needed, ERRT has shown strong support in reducing the number and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. This study will assess the efficacy in individuals diagnosed with bipolar disorder.

Read the detailed description

This pilot study will examine the efficacy of Exposure, Relaxation, \& Rescripting Therapy (ERRT) on chronic nightmares in trauma-exposed adults diagnosed with bipolar disorder (B-ERRT), as these individuals have been excluded from past clinical trials. Eligible participants will be assessed prior to starting treatment. B-ERRT will be conducted once a week for approximately five consecutive weeks for approximately two hours per session. Each treatment session focuses on one of the following topics/skills: psychoeducation regarding trauma, nightmares, and sleep disturbances on bipolar disorder, relaxation techniques, exposure to the trauma-nightmare, and relapse prevention. Participants will then be asked to complete two to three follow-up assessments, 1-week, 3-months, and potentially 1-year after the end of the treatment.

Being tested
ERRT-Bipolar Disorder
Keywords
Nightmares, Sleep, PTSD, Exposure, Relaxation, and Rescripting Therapy
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ERRT-Bipolar DisorderBehavioural

    Also called ERRT

    The nightmare treatment, called Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder, is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.

Study groups in NCT02242110
Study groupRoleWhat they receive
Nightmare TreatmentExperimentalThe nightmare treatment, Exposure, Relaxation, and Rescripting Therapy for Bipolar disorder (ERRT-Bipolar Disorder), is a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances in adults diagnosed with bipolar disorder.
Receives: Behavioral: ERRT-Bipolar Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Past Week Nightmare Frequency

    This fill-in-the-blank variable assesses the number of nightmares experienced in the past week (range = 0 - X nightmares) at each assessment (baseline, one week following treatment, and three months following treatment). Higher values indicate more nightmares (worse outcome).

    Measured: Pre, One week, Three Months

Secondary outcomes (1)
  1. Change in Clinician Administered PTSD Scale Symptoms

    This semi-structured clinical interview assesses severity of each of 30 items

    Measured: Pre, One week, Three Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2014 (estimated)
  2. Study startJun 2014
  3. Primary completion15 Aug 2026
  4. Study completion15 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02242110
Sponsor's protocol ID
TU1457R1
Acronym
BERRT
Status last verified
Sep 2026
First submitted
11 Sep 2014
Last updated
18 Sep 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Davis JL, Rhudy JL, Pruiksma KE, Byrd P, Williams AE, McCabe KM, Bartley EJ. Physiological predictors of response to exposure, relaxation, and rescripting therapy for chronic nightmares in a randomized clinical trial. J Clin Sleep Med. 2011 Dec 15;7(6):622-31. doi: 10.5664/jcsm.1466.

    PubMed 22171201

Questions about this trial

What is this clinical trial studying?

A study testing ERRT-Bipolar Disorder in people with Nightmares and Post-traumatic Stress Disorder, run by University of Tulsa at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Past Week Nightmare Frequency (time frame: Pre, One week, Three Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02242110, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in